glp-1 and protein intake Nutrition-First Support for Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance glp-1 therapy protein intake muscle

Half of the patients were taking GLP-1 drugs over this 10 year period, while the other half did not

Partner with Bioaura for the Next Generation 2026 Bioaura

To ensure the identification of all potentially relevant studies, reference lists of included publications were manually scrutinized

The speed of the development pipeline only adds to the challenge as GLP1 therapies are being used for approved indications beyond diabetes and obesity, including heart, liver and renal disease. With these evolving usage patterns, plan sponsors face a coverage dilemma defined by constant change and escalating financial exposure